On this episode of Virus Watch we cover three Zika virus stories: the first human trial of a Zika virus vaccine, the first local transmission of infection in the United States, and whether the virus is a threat to participants in the 2016 Summer Olympic and Paralympic Games.
Journalism professor David Tuller returns to TWiV for a discussion of the PACE trial for ME/CFS: the many flaws in the trial, why its conclusions are useless, and why the data must be released and re-examined. You can find TWiV #397 at microbe.tv/twiv, or listen below. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV397.mp3″] Click arrow to play Download TWiV 397 (67 MB …
By David Tuller, DrPH David Tuller is academic coordinator of the concurrent masters degree program in public health and journalism at the University of California, Berkeley. In 2010, the BMJ published the results of the Fatigue Intervention by Nurses Evaluation, or FINE. The investigators for this companion trial to PACE, also funded by the Medical …
On episode #319 of the science show This Week in Virology, the TWiVers review the outcomes of two recent phase 3 clinical trials of a quadrivalent dengue virus vaccine in Asia and Latin America. You can find TWiV #319 at www.microbe.tv/twiv.
On episode #278 of the science show This Week in Virology, Vincent, Dickson, Alan, and Kathy discuss disruption of the ccr5 gene in lymphocytes of patients infected with HIV-1. You can find TWiV #278 at www.microbe.tv/twiv.
Hosts: Vincent Racaniello and Scott Hammer, MD On episode #52 of the podcast “This Week in Virology”, Vincent and Dr. Scott Hammer talk about different types of AIDS vaccines and how they are tested in clinical trials. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV052.mp3″] Click the arrow above to play, or right-click to download TWiV #52 (51 MB .mp3, 71 …
